President Donald Trump is shaking up the public health establishment with a bold move on childhood vaccines.
As reported by Politico, in a stunning directive issued on Friday, December 5, 2025, Trump has tasked Health Secretary Robert F. Kennedy Jr. with reevaluating the U.S. childhood vaccine schedule to see if it measures up to practices in other developed nations.
This presidential memo, straight from the Oval Office, orders the Department of Health and Human Services and the CDC to dig into the science behind vaccination recommendations from peer countries and adjust the U.S. schedule if better approaches are found.
The timing of this directive couldn’t be more eyebrow-raising, coming just hours after federal vaccine advisers scaled back long-standing guidance on newborn hepatitis B shots.
On Thursday and Friday, December 4 and 5, 2025, the CDC’s Advisory Committee on Immunization Practices held sessions in Atlanta, where the U.S. vaccine schedule faced scrutiny compared to nations like Denmark, which administer fewer childhood shots.
Public health experts pushed back, arguing that countries like Denmark have smaller populations and robust universal health care systems with top-tier prenatal care—hardly a fair comparison to the American context.
Let’s not pretend this is a sudden pivot—Trump has long questioned the current childhood vaccine schedule, even raising concerns about links to autism despite scientific evidence debunking such claims.
His history of skepticism isn’t just idle chatter; Kennedy himself noted that Trump once asked him to lead a vaccine safety commission during his first transition, though that idea never materialized.
Now, with this memo, it seems Trump is doubling down, aiming to ensure American kids aren’t over-vaccinated compared to their global peers while still keeping current vaccines accessible.
Trump didn’t hold back on social media, declaring, “I am fully confident Secretary Robert F. Kennedy, Jr., and the CDC, will get this done, quickly and correctly, for our Nation’s Children,” as posted on Truth Social.
That’s a hefty vote of confidence, but let’s be real—entrusting this overhaul to Kennedy, a known vaccine skeptic, raises questions about whether science or suspicion will drive the outcome.
Trump also hailed the downgrade of newborn hepatitis B guidance as “a very good decision” on social media, signaling his approval of scaling back what many parents see as an overly aggressive schedule.
Meanwhile, CDC hepatitis expert Adam Langer pointed out a critical flaw in comparing the U.S. to other nations, stating, “In the United States, many of these infants are lost to follow-up as soon as they leave the hospital.”
Langer’s words cut deep—unlike Denmark, America’s fragmented health care system means kids often slip through the cracks, a reality that could complicate any attempt to mimic foreign vaccine protocols.
While Trump’s push for a review might resonate with parents frustrated by one-size-fits-all mandates, the risk of undermining proven protections in a country with unique challenges looms large. Let’s hope this isn’t a case of throwing out the baby with the bathwater in the name of rejecting progressive overreach.
